Quantcast
Home > Quotes > NTEC
NTEC

Intec Pharma Ltd. Ordinary Shares (NTEC) Quote & Summary Data

$8.19
*  
0.12
1.49%
Get NTEC Alerts
*Delayed - data as of Feb. 15, 2019  -  Find a broker to begin trading NTEC now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
12
Today's High / Low
$ 8.25 / $ 8.03
Share Volume
166,479
50 Day Avg. Daily Volume
274,036
Previous Close
$ 8.07
52 Week High / Low
$ 8.78 / $ 3.55
Market Cap
272,120,842
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.48

Intraday Chart

Shares Traded

Share Volume:
166,479
50 Day Avg. Daily Volume:
274,036

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.42

Trading Range

The current last sale of $8.19 is 130.70% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 8.25 $ 8.78
 Low: $ 8.03 $ 3.55

Company Description (as filed with the SEC)

Intec Pharma Ltd. was established and incorporated in Israel on October 23, 2000 as a private Israeli company under the name Orly Guy Ltd. In February 2001, our name was changed to Intec Pharmaceuticals (2000) Ltd. Our research and development activities began originally through a private partnership, Intec Pharmaceutical Partnership I.P.P, a general Israeli partnership, formed on September 21, 2000. Its operations were transferred in full to us at the beginning of 2002 in return for the allocation of shares in our Company to the partners in the partnership, pro rata with their ownership in the partnership. In March 2004, we changed our corporate name to Intec Pharma Ltd. In February 2010, we successfully completed an initial public offering in Israel on the TASE. In September 2017, the Company incorporated a wholly-owned subsidiary in the United States of America in the State of Delaware - Intec Pharma Inc.  ... More ...  


Risk Grade

Where does NTEC fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 8.05
Open Date:
Feb. 15, 2019
Close Price:
$ 8.19
Close Date:
Feb. 15, 2019

Consensus Recommendation

Analyst Info